Neuroendocrine and Pituitary
Tumor Clinical Center (NEPTCC) Bulletin
Winter 2018/2019 | Volume 24, Issue 2
Research Studies Available
Patients may qualify for research studies in the Neuroendocrine and Pituitary Tumor Clinical Center. We are currently accepting the following categories of patients for screening to determine study eligibility. Depending on the study, subjects may receive free testing, medication and/or stipends.
|Adults with active or treated acromegaly||•Quality of life
•Cross-sectional bone density study
•Study evaluating sustained control with oral octreotide
|Karen Pulaski Liebert, RN|
|Adults with active Cushing’s Syndrome||•Study with a twice daily oral therapy||Karen Pulaski Liebert, RN|
The Neuroendocrine and Pituitary Tumor Clinical Center is involved in many different research studies.
Types of studies and enrollment status changes frequently, so please call our
office (617-726-3870) or check our webpage (massgeneral.org/neuroendocrine) for more
information about potential studies which may not be listed here.